Skip to main content

Table 1 Characteristics of the Sample and its Subgroups at first clinic visit

From: Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more

Characteristic

Total Sample

Group 1 (G1)

Group 2 (G2)

P-value ¶

Sample size (n)

455

36

419

 

Sex: n (%)

    

   Male

334(73.4)

33 (91.7)

301 (71.8)

0.127

   Female

121(26.6)

3 (8.3)

118 (28.2)

 

HIV risk factor: n (%)

    

   IDU *

285(62.9)

2 (5.7)

283 (67.7)

< 0.001

   Heterosexual

123(27)

16 (44.4)

107 (25.5)

0.132

   MSM **

23(5.1)

4 (11.1)

19 (4.5)

< 0.999

   MSMW ‡

8(1.8)

6 (16.7)

2 (0.5)

< 0.001

   Unknown

16(3.5)

8 (22.2)

8 (2)

< 0.001

AIDS criteria: n (%)

    

   Yes §

57(12.5)

7 (19.4)

50 (11.9)

< 0.999

   No

398(87.5)

29 (80.6)

369 (88.1)

 

Previous treatment: n (%)

    

   Yes

181(39.8)

2 (5.6)

179 (42.7)

< 0.001

   No

274(60.2)

34 (94.4)

240 (57.3)

 

CD4 (n° cel./mm3)

352.08 ± 294.10

180.83 ± 230.85

366.90 ± 294.52

< 0.001

CD8 (n° cel./mm3)

957.82 ± 597.10

963.38 ± 733.22

956.97 ± 583.73

< 0.999

Plasma viral load (log10)

4.09 ± 1.22

4.51 ± 1.18

4.05 ± 1.22

0.451

HBsAg #: n (%)

    

   Positive

24(8.1)

1 (4.5)

23 (8.3)

< 0.999

   Negative

274(91.9)

21 (95.5)

253 (91.7)

 

Anti-HCV: n (%)

    

   Positive

197(56.8)

3 (13.6)

194 (65.1)

< 0.001

   Negative

123(43.2)

19 (86.4)

104 (34.9)

 
  1. P value adjusted by Bonferroni procedure; * IDU: Injection drug user; ** MSM: Men who have sex with men; Fisher exact test; ‡ MSMW: Men who have sex with men or women; § AIDS criteria: Centers for Disease Control and Prevention (CDC) category C; # HBsAg: Hepatitis B superficial antigen